The Centers for Medicare & Medicaid Services today announced five new Center for Medicare and Medicaid Innovation payment models aimed at transforming kidney care so that patients with chronic kidney disease have access to high-quality, coordinated care. The proposed End-Stage Renal Disease Treatment Choices model would be mandatory for certain areas of the country; four other models are voluntary. The ETC model, which would include dialysis facilities and managing clinicians, would provide new incentives to encourage dialysis in the home. The payment adjustments under the proposed ETC model would begin Jan. 1, 2020, and end June 30, 2026. CMMI said the four optional payment models are expected to enroll more than 200,000 Medicare patients in arrangements that give providers new incentives for preventing kidney disease and managing kidney patients’ health more comprehensively. The payment models are in response to an executive order signed today by President Trump on advancing kidney health. 

Related News Articles

Headline
The 5th U.S. Circuit Court of Appeals Feb. 9 affirmed a district court ruling upholding Louisiana’s 340B contract pharmacy law. The state law prohibits…
Headline
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…
Blog
Public
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing…
Headline
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…
Headline
A JAMA study released Jan. 22 found that colorectal cancer is the leading cause of cancer deaths in people under age 50. The study examined cancer mortality in…